Johnson & Johnson completes $17bn acquisition of Abiomed

Raghuram Kadari- December 28, 2022 0

Johnson & Johnson (J&J) has closed the previously announced acquisition of Abiomed, a medical device technology company, for an enterprise value of around $16.6bn, in ... Read More

Johnson & Johnson to purchase heart pump maker Abiomed for $16.6bn

Raghuram Kadari- November 2, 2022 0

Johnson & Johnson (J&J) has agreed to acquire Abiomed, a NASDAQ-listed cardiovascular medical technology provider, in an all-cash deal valued at approximately $16.6 billion. The ... Read More

Healthcare giant Johnson & Johnson to spin off consumer health business

Pallavi Madhiraju- November 15, 2021 0

Johnson & Johnson (JNJ) has announced plans to carve out its consumer health business into a new publicly traded company to focus on its biopharma ... Read More